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February 2011558 Abstractsdure, and the use of protamine. The results were analyzed and used for
comparison between the use of these medications for CEA vs CAS.
Results: Of 2434 recipients who were sent a questionnaire, 653 (27%)
participated in the survey. Of these 653 participants, 649 (99%) stated that
they perform CEA and 598 (93%) perform CAS. Of the 649 vascular
surgeons that perform CEA, 85% use aspirin alone preoperatively. Plavix was
used by 4%, and both were used by 9.7%. Ninety-nine percent use heparin
during the procedure, and 48% use protamine to reverse the heparin dose.
Of the 598 vascular surgeons that performCAS, only 41% use a combination
of aspirin and Plavix before the procedure. Aspirin alone was used by 26.8%
and Plavix alone by 45.3%. Ninety-three percent use heparin during the
procedure (6.2% used bivalirudin), and only 16% reversed the heparin dose
with protamine. Platelet inhibition before either intervention is almost never
assessed (3.5% with CEA and 3.9% with CAS).
Conclusions: These results suggest that there is no difference between
the numbers of vascular surgeons performing carotid endarterectomy com-
pared with carotid artery stent placement. Conversely, there is a substantial
difference in the selection of antiplatelet medications before the two proce-
dures. In addition, there is a large difference in the administration of
protamine after CEA compared with CAS. This survey suggests that there is
no standard practice on the use of preprocedural medications or the use of
protamine sulfate for heparin reversal during carotid procedures.
Carotid Surgery Is the Gold Standard for High-Risk (HRP) Carotid
Artery Intervention: Five-Year Cost-Effectiveness and Quality Stroke-
Free Survival Comparison Between Carotid Endarterectomy (CEA),
Carotid Angioplasty, and Stenting Technique (CAST), and Optimal
Medical Therapy (OMT)
NiamhHynes,MD,MRCS,MMSc Endo, Sherif Sultan,MD, FRCS, FACS,
Western Vascular Institute, Galway, Ireland.
Background: Our aim was to conciliate carotid angioplasty and stent-
ing technique (CAST) with CEA and optimal medical therapy (OMT) in
high-risk patients. Primary end points were stroke, myocardial infarction, or
death. Secondary end points were patency rate, cost-effectiveness, length of
hospital stay, reintervention rate, quality of life, Q-TwiST (Quality-Adjusted
TimeWithout Symptoms of Disease or Toxicity of Treatment), and cost per
quality-adjusted life-year (QALY).
Methods: Between October 2001 and October 2008, 847 patients
were evaluated with carotid stenosis 60%. Predicted probability of receiv-
ing CEA, CAST, and OMTwas tabulated using multiple logistic regressions
to control for comorbidity and anatomic high-risk factors. Propensity scor-
ing adjusted for baseline characteristics and selection bias by matching
covariables, creating a pseudorandomized control design for 306 CEA, 39
CAST, and 275 OMT, of which computer randomization generated 55
CEA, 34 CAS, and 67 OMT. Nineteen (6.3%) had bilateral interventions.
Comorbidity Severity Scores were similar between groups (P  .05)
Results: All interventions were within a mean of 18 days from initial
presentation. Mean age was similar between CEA (68.6 years) and CAST
(70.6 years, P .05) but OMT patients were significantly older (75.4 years)
than CEA (P .01) or CAST patients (P .05). Duplex ultrasound was the
sole preoperative imagingmodality to quantify plaque-typemorphology and
degree of stenosis. After carotid intervention, overall 30-day stroke free
survival rate was 99.1% (95% CI, 99.6%-99.9%). The 5-year stroke-free rate
was 99.1% (95% CI, 99.6%-99.9%), stroke-free survival was 90.6% (95% CI,
85.9%-93.9%), and primary patency was 94.6% (95% CI, 90.5%-97.0%). The
5-year stroke free survival significantly improved with CEA (90.6%) com-
pared with OMT (44.3%, H  .22; 95% CI, .08-.61; P  .0001). Cox
proportional hazards ratio showed age80 years (P .001), female gender
(P  .04), and echolucent plaque material (P  .01) were associated with
reduced stroke free survival. Q-TwiST, and cost per QALY were in favor of
CEA vs CAST (P .05) and significantly improved with CEA vs OMT (P
.0001) and CAST (P  .001).
Conclusions: OMT does not prevent future stroke in patients with
severe carotid artery disease. Indications for CAST are limited, and strict
selection criteria should apply. Contemporary trends verify that stenting
techniques and cerebral protection devices prerequisite device maturity
before it befalls routine clinical practice. CEA is the gold standard in suitable
patients with recently symptomatic carotid artery stenosis, with superior
stroke-free survival rates at 5 years when compared with CAST or OMT.
Characterization of Resident Surgeon Participation During Carotid
Endarterectomy and Impact on Perioperative Outcomes
James Reeves, MD, Gabriela Velazquez-Ramirez, MD, Thomas F. Dodson,
MD, David McClusky, MD, Karthikeshwar Kasirajan, MD, Ravi
Veeraswamy, MD, Atef Salam, MD, Elliot Chaikof, MD, PhD, Matthew A.
Corriere, MD, MS, Emory University School of Medicine, Atlanta, Ga.
Objectives: The impact of resident care on vascular patient outcomes
has not been well characterized. We analyzed resident surgeon participation
during carotid endarterectomy (CEA), procedural characteristics, and asso-
ciations with perioperative outcomes using the 2005-2008 American Col-
f
rege of Surgeons National Surgical Quality Improvement Program (NSQIP)
ata file.
Methods: CEAs were identified using primary CPT codes. Compari-
ons based on resident participation were performed using 2 or Fisher exact
est for categoric variables and t tests or nonparametric methods for contin-
ous variables. Associations with complications (major: stroke, death, or
yocardial infarction; minor: reoperation, reintubation, bleeding, or nerve
njury) were assessed using logistic regression.
Results: Residents were scrubbed for 9937 of 17,542 CEAs analyzed
56.7%). Resident level was categorized as junior (postgraduate year [PGY]
-2) in 20.9%, senior (PGY 3-5) in 52.9%, and fellow (PGY6) in 26.2% of
EAs. Preoperative and procedural data based on resident participation
tatus are reported the Table. Patients undergoing CEA who had a resident
crubbed had a longer mean anesthesia time (197 vs 159 minutes; P 
0001) but shorter hospital stays (39.5% vs 43.8% of patients hospitalized1
ay; P .0001). Multivariable models did not reveal significant associations
etween resident participation and risk of major or minor complications.
Conclusions: Although resident participation during CEA was associ-
ted with longer anesthesia times, no effect on complications was observed
nd length of stay was shorter when residents were scrubbed. Resident
ontributions to postoperative care may favorably impact outcomes, and
ssessment of resident impact should not be limited to procedural factors.
able. Preoperative and procedural data based on
esident participation
Variable
Resident
PAbsent Present
ge, years 71.2 70.5 .0001
eight, kg 80.4 80.6 NS
emale, % 41.8 40.4 NS
iabetes 26.9 27.3 NS
ypertension, % 85.2 85.3 NS
oronary disease, % 37.6 36.4 NS
urrent smoker, % 27.7 27.7 NS
ematocrit, % 39.5 39.5 NS
BC, 103/uL 7.7 7.7 NS
erum creatinine, mg/dL 1.19 1.17 NS
reoperative TIA, % 28.6 28.1 NS
reoperative stroke, % 23.6 24.1 NS
eneral anesthesia, % 84.6 82.3 .0001
SA class  III, % 91.1 89.0 .0001
mergent procedure, % 1.7 1.8 NS
nesthesia time, min 158.9 196.6 .0001
ntra-op transfusion, U 0.02 0.03 NS
he Malignant Course of Carotid Artery Occlusion: Risk Factor and
utcomes
arren Bryan, BA,1 John Carson, MD,2 Qi He, MD,3 Khalil Qato, BA,4
isham Bassiouny, MD,3 Christopher L. Skelly,3 1University of Rochester
chool of Medicine and Dentistry, Rochester, NY; 2University of California,
avis, Mather, Calif; 3University of Chicago Hospitals, Chicago, Ill; 4New
ork Medical College, Valhalla, NY.
Objective: This study evaluated the long-term outcomes of patients
ith carotid artery occlusion and determined risk factors predictive of death,
eurologic event, or contralateral carotid intervention.
Methods: Patients with carotid occlusion shown by duplex ultrasound
maging were retrospectively identified and followed-up between January
002 and June 2010 (mean, 52 months; range, 1-93 months) at a tertiary
are hospital. All had a minimum of three duplex examinations available for
eview. Analysis by 2 was used to determine risk factors for death, neuro-
ogic event, or contralateral intervention. Multivariate Cox proportional
azard analysis was conducted with P values  0.1. Survival was estimated
sing the Kaplan-Meier method (P  .05 significant).
Results: Eighty patients with comorbidities commensurate for a ter-
iary care center were identified and available for analysis. At the initial
ncounter, 30 (38%) were symptomatic, with 23 (29%) having symptoms
eferable to the occluded carotid. During follow-up, 7 (9%) had a neurologic
vent, of which 6 (86%) were referable to the occluded side; 14 (18%)
nderwent a contralateral operation, and 19 (24%) died. Multivariate anal-
sis revealed amaurosis fugax at initial presentation was a risk factor for
ontralateral operation (P .05). Although numerous variables of multives-
el disease were significant with 2 analysis, there was no significant risk
actor associated with neurologic event upon multivariate analysis. Neck
adiation (P  .05) and stenosis or occlusion of the external carotid
